Bonk, Inc. (NASDAQ: BNKK), formerly known as Safety Shot, Inc., reported significant financial developments in its recent 10-K filing for the fiscal year ending December 31, 2025. The company generated total revenues of $3.93 million, a substantial increase from $701,967 in the previous year, primarily driven by the acquisition of Yerbaé Brands and the initiation of digital asset investments. However, Bonk reported a net loss of $68.19 million, compared to a loss of $49.41 million in 2024, reflecting ongoing operational challenges and increased expenses.
The company’s operating expenses rose to $40.68 million in 2025 from $39.61 million in 2024, with significant costs attributed to marketing, legal fees, and stock-based compensation. Notably, the impairment expense of $4.95 million related to intangible assets contributed to the overall loss. Despite these challenges, Bonk's gross profit improved to $1.24 million, contrasting with a gross loss of $2.45 million in the prior year, indicating a positive shift in product sales performance.
Strategically, Bonk has undergone several key developments, including the acquisition of Yerbaé Brands on June 27, 2025, which expanded its footprint in the functional beverage market. The company also launched its Sure Shot Dietary Supplement in December 2023, a product designed to aid in alcohol metabolism. Additionally, Bonk has entered the digital asset space, acquiring Bonk tokens as part of its treasury strategy, which it plans to leverage for future growth.
Operationally, Bonk reported a workforce of ten full-time employees and emphasized its commitment to innovation and product development. The company has shifted its focus away from CBD products, which it no longer markets, and is exploring new product lines to meet evolving consumer demands. The filing also highlighted the company's reliance on third-party manufacturers for its products, which poses risks related to quality control and supply chain management.
Looking ahead, Bonk's management expressed concerns regarding its ability to continue as a going concern, citing significant accumulated deficits and cash flow challenges. The company plans to pursue additional capital to support its operations and growth initiatives, although it acknowledges the risks associated with raising funds, including potential dilution of existing shareholders. The outlook remains cautious as Bonk navigates its transition into new markets and product lines while managing its financial health.
About Safety Shot, Inc.
Safety Shot, Inc. develops and commercializes dietary supplements aimed at reducing blood alcohol content. Its flagship product, Sure Shot, contains 28 GRAS ingredients and is marketed through e-commerce and retail stores. The company emphasizes innovation, clinical research, and quality manufacturing, focusing on health and wellness markets. It owns patents related to alcohol metabolism support and collaborates with partners to expand product offerings and distribution channels.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.